Wand G S, May V, Eipper B A
Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21205.
Endocrinology. 1988 Aug;123(2):1153-61. doi: 10.1210/endo-123-2-1153.
The acute and chronic effects of secretagogues activating cAMP-dependent pathways (CRH and cAMP) and activating cAMP-independent pathways [phenylephrine and phorbol 12-myristate 13-acetate (PMA)] on anterior pituitary function were examined in serum-free cultures. Applied acutely, PMA produced a greater stimulation of ACTH/endorphin secretion than CRH or cAMP. However, the effects of CRH and cAMP on secretion were maintained for up to 12 days, while those of PMA and phenylephrine diminished rapidly. Secretagogue effects on pro-ACTH/endorphin biosynthesis were determined by immunoprecipitation of biosynthetically labeled beta-endorphin-related peptides. Cultures exposed to CRH or cAMP and [3H]tyrosine for 12 h produced 1.7 +/- 0.2- and 1.6 +/- 0.1-fold more newly synthesized beta-endorphin-related material than control cells. Cultures exposed to phenylephrine or PMA synthesized 1.3 +/- 0.1- and 1.4 +/- 0.1-fold more peptide than control cells. Exposure of cells to CRH or cAMP for 12 days increased pro-ACTH/endorphin biosynthesis to a greater extent than the 12-h treatment (3.0 +/- 0.1- and 2.5 +/- 0.3-fold over control value, respectively). Exposure to phenylephrine or PMA for 12 days had the same effect on pro-ACTH/endorphin biosynthesis as exposure for 12 h. After acute or chronic secretagogue exposure, the cells secreted relatively more newly synthesized beta-lipotropin than beta-endorphin. Levels of pro-ACTH/endorphin mRNA in cultures treated acutely (12 h) or chronically (12 days) with CRH, cAMP, or phenylephrine changed in parallel with rates of pro-ACTH/endorphin biosynthesis. In contrast, chronic exposure to PMA stimulated biosynthesis while reducing pro-ACTH/endorphin mRNA levels. In summary, these results suggest that factors that activate cAMP-dependent pathways are more powerful stimulators of pro-ACTH/endorphin biosynthesis than factors that activate cAMP-independent pathways; the cAMP-dependent pathway may be primarily responsible for regenerating depleted hormone reserves.
在无血清培养中,研究了激活cAMP依赖性途径(促肾上腺皮质激素释放激素和cAMP)和激活cAMP非依赖性途径[去甲肾上腺素和佛波酯12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)]对垂体前叶功能的急性和慢性影响。急性应用时,PMA对促肾上腺皮质激素/内啡肽分泌的刺激作用比促肾上腺皮质激素释放激素或cAMP更大。然而,促肾上腺皮质激素释放激素和cAMP对分泌的影响可持续长达12天,而PMA和去甲肾上腺素的影响迅速减弱。通过对生物合成标记的β - 内啡肽相关肽进行免疫沉淀来确定促分泌素对促肾上腺皮质激素原/内啡肽生物合成的影响。用促肾上腺皮质激素释放激素或cAMP以及[3H]酪氨酸处理12小时的培养物产生的新合成的β - 内啡肽相关物质比对照细胞多1.7±0.2倍和1.6±0.1倍。用去甲肾上腺素或PMA处理的培养物合成的肽比对照细胞多1.3±0.1倍和1.4±0.1倍。细胞用促肾上腺皮质激素释放激素或cAMP处理12天比12小时处理更能增加促肾上腺皮质激素原/内啡肽的生物合成(分别比对照值高3.0±0.1倍和2.5±0.3倍)。用去甲肾上腺素或PMA处理12天对促肾上腺皮质激素原/内啡肽生物合成的影响与处理12小时相同。急性或慢性促分泌素处理后,细胞分泌的新合成的β - 促脂素相对比β - 内啡肽更多。用促肾上腺皮质激素释放激素、cAMP或去甲肾上腺素急性(12小时)或慢性(12天)处理的培养物中促肾上腺皮质激素原/内啡肽mRNA水平的变化与促肾上腺皮质激素原/内啡肽生物合成速率平行。相反,慢性暴露于PMA刺激生物合成,同时降低促肾上腺皮质激素原/内啡肽mRNA水平。总之,这些结果表明,激活cAMP依赖性途径的因素比激活cAMP非依赖性途径的因素更能有力地刺激促肾上腺皮质激素原/内啡肽的生物合成;cAMP依赖性途径可能主要负责补充耗尽的激素储备。